About the Authors
- Carmen Pin
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft
* E-mail: carmen.pin@astrazeneca.com
Affiliation Systems Medicine, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom
- Sylvia Taylor
-
Roles Conceptualization, Funding acquisition
Affiliation Medical and Scientific Affairs, Vaccines & Immune Therapies, Biopharmaceuticals, AstraZeneca, Cambridge, United Kingdom
- Catia Ferreira
-
Roles Conceptualization, Funding acquisition
Affiliation Medical and Scientific Affairs, Vaccines & Immune Therapies, Biopharmaceuticals, Wilmington, United States of America
- Sofie Arnetorp
-
Roles Conceptualization, Funding acquisition
Affiliation Health Economics, BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden
- Holly Kimko
-
Roles Conceptualization, Investigation, Writing – review & editing
Affiliation Systems Medicine, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, United States of America
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: all authors are (or were at the time they contributed to this work) AstraZeneca employees and may own stocks or shares in AstraZeneca. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.